Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry

Get report
Skip to content

Frost & Sullivan ranks RapidAI's enterprise platform ahead of 96% in the industry

Get report
  • There are no suggestions because the search field is empty.
Request a Demo
Request a Demo

Core Capabilities

Featured

Radar metrics
BLOG The market has changed: Frost & Sullivan's 2026 Radar shows who's leading it RapidAI Chief Business Officer David Stoffel, MD, MBA, breaks down what this recognition signals — and what it means for health systems planning their AI strategy for the years ahead LEARN MORE
Platform overview
Request a Demo

RADIOLOGY SUPPORT

Neurovascular

Cardiac + vascular

LIFE SCIENCES

Featured

Cognitive Burden index RapidAI 2025
BLOG Radiology’s real challenge Read about the reality of cognitive burden LEARN MORE
Request a Demo

BUILT TO SUPPORT THE FULL SYSTEM

FEATURED

Resource_1600x900_C-Suite-Exec Insights_white paper
WHITE PAPER Empowering healthcare leaders with a deep clinical AI enterprise platform Learn how AI can address real-world challenges for administrators LEARN MORE
Overview
Request a Demo

Core Capabilities

Featured

Radiology Rewired podcast
PODCAST Season 1 available now Exploring how AI is transforming Radiology—one conversation at a time with clinicians and innovators LEARN MORE
Overview
Request a Demo

TRAINING & LEARNING

HELP & ASSISTANCE

Overview
Request a Demo

LEARN MORE ABOUT RAPIDAI

WORK WITH US

FEATURED

video thumbnail for dr Gregory Albers
VIDEO The story behind RapidAI Hear our founder, Greg Albers, MD, tell the history of how the company came to be Watch now
Company overview
Request a Demo
Press Release

iSchemaView Completes MDSAP Audit, Moves to Expand Worldwide Adoption of Rapid Imaging Platform

Critical International Audit Paves Way for Regulatory Application and Approvals Around the World. Canadian Representative Launched.

Share to

Critical International Audit Paves Way for Regulatory Application and Approvals Around the World. Canadian Representative Launched.

Redwood City, Calif. – June 5, 2018 – iSchemaView, the leader in cerebrovascular imaging analysis, today announced that the company has completed the Medical Device Single Audit Program (MDSAP), with coming certification. iSchemaView is now applying for clearances and approvals of the RAPID imaging platform in all participating countries around the world. In 2014, the International Medical Device Regulators Forum (IMDRF) launched a global approach to auditing and monitoring the manufacturing of medical devices, in an effort to improve safety and oversight on an international scale. The result was the creation of the MDSAP, a regulatory audit that serves as a critical step in satisfying the relevant requirements of international regulatory authorities. MDSAP participating countries include Australia, Brazil, Canada, Japan and the United States, with the World Health Organization and European Union among official observers. “With dozens of new stroke centers installing RAPID’s automated CTP, MR, CTA and ASPECTS solutions each month, we are seeing accelerating adoption this year,” said Don Listwin, CEO of iSchemaView. “Now that we have completed the MDSAP we are looking to ensure that patients to our North, and around the world, can take advantage of our unmatched imaging solutions. Our mission is to help health care systems address and treat more stroke patients than ever before, and this news moves us ever more swiftly down the path of success.” With MDSAP complete, iSchemaview will be pursuing approval for RAPID in all participating countries, with estimated clearance in Canada expected this summer. In lock-step with the process, iSchemaview is also announcing that Kevin Talmage of Yocan Medical Systems will partner with the company as a Canadian region representative. Talmage brings with him over twenty years of successful medical device marketing and sales experience across Canada. For more information about working with RAPID in Canada, contact Kevin Talmage at (647) 271- 2516 or at kevin.talmage@yocanmedical.ca .

Contact PR

Jessica Stebing

Jessica Stebing

Group Manager, Marketing Communications

stebing@rapidai.com